A delayed clinical trial actually boosted Bristol Myers Squibbâs stock. Hereâs why.
Bristol Myersâ stock rallied Wednesday as investors maintained high hopes for Cobenfy as an Alzheimerâs treatment, even though the outcome âŚ
Real-time market intelligence across asset classes
Bristol Myersâ stock rallied Wednesday as investors maintained high hopes for Cobenfy as an Alzheimerâs treatment, even though the outcome âŚ
Two of Wall Streetâs biggest firms say the AI boom isnât a bubble, arguing real spending and earnings support the âŚ
Investors and energy analysts question whether the AI race has turned into a bubble, one that would be costly to âŚ
Goldman Sachs Group Inc. macro trader Bobby Molavi likens the setup for stocks heading into the new year to a âŚ
The oil industry group the American Petroleum Institute has lobbied the Trump administration to repeal the Biden fuel economy standards.
You can catch Trader Talk on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. Bitcoin's (BTC-USD) sharp drop âŚ
Multi-Provider AI Analysis